Mr. Chair, I listened closely to my colleague. As the research and innovation critic, I was also interested in the Medicago file. Let me reiterate what happened.
The government launched several calls for proposals, three or four. A firm called AbCellera received its funding in short order. Medicago received a letter from the government in mid-April, I believe, stating that the firm would soon receive a letter outlining the terms and conditions. There was a lot of back and forth, and Medicago did not receive the letter until early July, if memory serves. AbCellera managed to get its letter very quickly, while Medicago had to wait three or four months. Investors were nervous.
I still wonder what could explain the government's unacceptable delay in responding to Medicago.